(0.27%) 5 145.50 points
(0.30%) 38 555 points
(0.36%) 17 910 points
(-0.82%) $83.16
(1.35%) $1.949
(-0.15%) $2 343.70
(0.18%) $27.59
(0.86%) $930.00
(-0.32%) $0.932
(-0.39%) $10.98
(-0.42%) $0.797
(0.25%) $92.11
0.50% IDR 4 020.00
Live Chart Being Loaded With Signals
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines...
Stats | |
---|---|
Dzisiejszy wolumen | 6 500.00 |
Średni wolumen | 55 596.00 |
Kapitalizacja rynkowa | 1 800.96B |
EPS | IDR87.11 ( 2023-09-30 ) |
Następna data zysków | ( IDR0 ) 2024-05-29 |
Last Dividend | IDR0 ( N/A ) |
Next Dividend | IDR0 ( N/A ) |
P/E | 10.10 |
ATR14 | IDR11.56 (0.29%) |
PT Merck Tbk Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PT Merck Tbk Finanse
Annual | 2023 |
Przychody: | IDR961.43B |
Zysk brutto: | IDR391.73B (40.74 %) |
EPS: | IDR397.86 |
FY | 2023 |
Przychody: | IDR961.43B |
Zysk brutto: | IDR391.73B (40.74 %) |
EPS: | IDR397.86 |
FY | 2022 |
Przychody: | IDR1 124.60B |
Zysk brutto: | IDR427.59B (38.02 %) |
EPS: | IDR401.42 |
FY | 2021 |
Przychody: | IDR1 064.39B |
Zysk brutto: | IDR398.68B (37.46 %) |
EPS: | IDR293.89 |
Financial Reports:
No articles found.
PT Merck Tbk
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it leases and manages properties. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej